{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:11:58Z","timestamp":1778800318049,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"The Swedish Heart Lung Foundation","doi-asserted-by":"publisher","award":["20230599"],"award-info":[{"award-number":["20230599"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cmi.2026.03.034","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:30:06Z","timestamp":1775604606000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular epidemiology and genetic determinants of \u03b2-lactam resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Stockholm, Sweden"],"prefix":"10.1016","author":[{"given":"Elin","family":"Loo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya","family":"Tellapragada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Giske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.03.034_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2015.09.007","article-title":"Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis","volume":"15","author":"Qvist","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.cmi.2026.03.034_bib2","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1093\/infdis\/jiae051","article-title":"Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosis","volume":"230","author":"Ledger","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.03.034_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis","volume":"31","author":"Parkins","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2026.03.034_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.03.034_bib5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.cmi.2021.05.011","article-title":"GEMARA-SEIMC\/REIPI Pseudomonas study Group. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis","volume":"27","author":"Cortes-Lara","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.03.034_bib6","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/ppul.27202","article-title":"Detection of the epidemic Pseudomonas aeruginosa AUST-03 (ST242) strain in people with cystic fibrosis in South Africa","volume":"59","author":"Hamiwe","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.cmi.2026.03.034_bib7","article-title":"Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395","volume":"3","author":"Petitjean","year":"2017","journal-title":"Microb Genom"},{"key":"10.1016\/j.cmi.2026.03.034_bib8","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/jac\/dkae203","article-title":"Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to \u03b2-lactams but inhibit cell division","volume":"79","author":"Glen","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.03.034_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.eimc.2024.08.013","article-title":"Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: results of a national multicentre study","volume":"43","author":"Maruri-Aransolo","year":"2025","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)."},{"key":"10.1016\/j.cmi.2026.03.034_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/apm.13331","article-title":"Antimicrobial resistance of Pseudomonas aeruginosa in a cystic fibrosis population after introduction of a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"131","author":"Katzenstein","year":"2023","journal-title":"APMIS"},{"key":"10.1016\/j.cmi.2026.03.034_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cmi.2023.12.026","article-title":"Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID\/ISARPAE Group","volume":"30","author":"Oliver","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.03.034_bib12","doi-asserted-by":"crossref","first-page":"538.e7","DOI":"10.1016\/j.cmi.2022.11.014","article-title":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"29","author":"L\u00f3pez-Causap\u00e9","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.03.034_bib13","doi-asserted-by":"crossref","first-page":"dlae183","DOI":"10.1093\/jacamr\/dlae183","article-title":"Investigation of cefiderocol resistance prevalence and resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa, Germany 2019\u201321","volume":"6","author":"Kocer","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2026.03.034_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01928-24","article-title":"Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient","volume":"13","author":"Vi\u00f1es","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2026.03.034_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:51:19Z","timestamp":1778799079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"alternative-id":["S1198743X26001722"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.03.034","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular epidemiology and genetic determinants of \u03b2-lactam resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Stockholm, Sweden","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}